The Jon and Marc Podcast

Jon and Marc
  • 5.0 (3)
  • Marketing
  • Updated Weekly

Legal growth insights from Jon, Marc, and the industry's top tier legal & marketing professionals. Two veteran legal marketers, Jon Robinson and Marc Rioux, dive into the business of law, mass torts, and the future of plaintiff-side firms. From marketing strategy and technology to candid conversations with top trial lawyers, marketers, and industry leaders, this podcast unpacks what’s really driving growth and change in the legal world. Honest, practical, and a little irreverent—perfect for attorneys, marketers, and anyone curious about where the business of law is headed.

  1. 2d ago

    Spinal Cord Stimulator, JPML Decisions & What’s Next for Mass Torts at MTMP

    Key Takeaways Spinal Cord Stimulators Split into Separate MDLs: The JPML granted the petitions to establish distinct MDLs for Nevro and Abbott. Alongside Boston Scientific, there are now three active SCS MDLs across federal courts in California and Illinois. Uber Settles 3rd Bellwether After Jury Selection: Uber selected a jury in the U.S. District Court for the Western District of Texas before settling the third bellwether case. Leadership continues pushing toward a potential global resolution for the ~5,000 pending rideshare sexual abuse claims. Camp Lejeune Leadership Reappointed & Mediation Deadlines: Executive leadership has been reappointed in the Camp Lejeune litigation as weekly mediation sessions proceed. Pressure continues to build with upcoming kidney cancer bellwether trials in North Carolina federal court. Bard PowerPort Defends Bellwether Schedule: The MDL judge in Arizona denied the defense's motion to dismiss the upcoming infection bellwether trial, paving the way for back-to-back trials in late 2026. Pre-MTMP Docket Momentum: Traditional medical device litigations are maintaining strong trial momentum alongside tech-driven mass torts as attorneys prepare to gather at the Bellagio in Las Vegas for MTMP.

  2. 4d ago

    Psychics or Idiots? Revisiting Our 2026 Legal Marketing Predictions at the Start of Q4

    Jon and Marc are heading into Q4 2026 and it's time to answer for themselves: what happened to the eight predictions they made at the start of the year? In this episode, they go prediction by prediction, what they got right, what they got wrong, and what's still playing out. Key Takeaways: Private Equity Law Firm Buyouts Are Accelerating: MSO structures and private equity investment give firm founders true exit strategies beyond traditional internal partner buyouts. State Advertising Regulations Are Creating Friction Across State Lines: Strict laws like California SB 37 restrict out-of-state firms from advertising without a physical office, forcing mass tort practices to adapt. Legal Tech Consolidation Lagged Due to Custom AI Development: Software platforms avoid expensive acquisitions because developers can replicate complex feature sets using AI coding tools for a fraction of the cost. Direct Response Attribution Is Failing Without Full-Funnel Strategy: Search traffic across major engines continues to drop due to AI overviews, making holistic multi-channel media operations essential for firm stability. Creative Volume Remains the Primary Obstacle in OTT and Social Ad Transition: Running successful streaming and social ad campaigns requires high volumes of fresh video creative rather than relying on a single static TV spot. Authentic Content Beats High-Production Legal Videos: Social media algorithms favor retention, watch time, and user sharing over follower counts, giving individual attorneys a clear path to build personal brands. Law Firms Are Demanding Real ROI From Tech and Conference Vendors: Firm owners are actively pushing back against overpriced software and marketing services that fail to yield solid business outcomes.

  3. Oct 1

    Pre-MTMP Mass Tort Power Rankings: Top 10 Litigations to Watch in 2026

    Key Takeaways Chlorpyrifos Emerges as the Next Chemical Tort: Following the Paraquat and Roundup playbooks, Chlorpyrifos pesticide litigation linking exposure to Parkinson’s disease is quietly gaining traction among top-tier mass tort firms in state court filings. Spinal Cord Stimulators & Weight Loss Drugs Surge: Weight Loss Drug litigation cracked the top 3 due to growing national exposure around eye injury (NAION) claims, while Spinal Cord Stimulators are predicted to be the focal point of MTMP with three separate manufacturer MDLs forming. Closing Acquisition Windows on Mature Torts: Mature litigations like Bard PowerPort (fresh off a major second bellwether win) and Hair Relaxer are entering their late stages, giving firms a narrow 6 to 8-month window to file remaining high-value inventory before 2027 trials kick off. Delays & Tiering in Scope and Rideshare Litigation: Olympus Scope MDL consolidation is pushing into early 2027 as firms refine injury tiering, while Uber/Lyft litigation sees a shift toward Lyft filings as Uber bellwethers and individual inventory settlements progress.

  4. Sep 29

    Why Most Legal Marketing Podcasts Fail (And How to Fix Yours)

    Key Takeaways Scaling a high-quality weekly podcast requires a full 7-person operation spanning talents, cinematography, editing, strategy, and clip distribution rather than a single solo editor.Viewers gain far more actionable value when legal shows skip generic origin stories and focus strictly on operational playbooks, firm growth, technology, and taxation.In-person studio setups create authentic rapport, distinct production depth, and candid conversations that cannot be replicated over virtual calls.Short-form video algorithms reward strong hooks in the first three seconds, while long-form YouTube performance relies heavily on retaining viewers through the initial 30 seconds.Applying the principle of extreme ownership across production workflows ensures content quality remains high as publishing volume increases.Unexpected topics like specialized tax strategies can outperform standard marketing clips when delivered with concrete details.

  5. Sep 24

    Navigating Mass Tort Settlements: The 95% Participation Threshold & Depo-Provera Rules

    Key Takeaways Spinal Cord Stimulators: Following the initial Boston Scientific MDL, pending JPML petitions for Abbott and Nevro will likely result in three distinct manufacturer-specific MDLs, with combined case volume projected to reach 15,000+. Talcum Powder Settlement: Law firms are actively working to reach the crucial 95% participation threshold for the $5.5B uncapped settlement, which could unlock up to $3B in claimant distributions before the end of 2027. Depo-Provera Administrative Docket: Judge Rogers created an administrative docket for settling cases, setting a strict November 30 deadline for non-settling plaintiffs to file on the traditional docket and satisfy Lone Pine requirements. Video Game Addiction Momentum: Denied an MDL twice due to multi-defendant complexity, the litigation is advancing via a California JCCP, with inventory settlement discussions emerging with key defendants like Microsoft. MTMP "Bell of the Ball" Predictions: Heading into Mass Torts Made Perfect, the hosts highlight Social Media Addiction (SMA) and Spinal Cord Stimulators as top litigations driving industry focus and firm investment.

  6. Sep 22

    Mike Morse's No-BS Framework for Law Firm Leadership

    Key Takeaways Delegating operational management to an executive operator frees law firm founders to concentrate strictly on marketing, firm vision, and attorney development. Scaling a practice beyond eight figures requires firm owners to identify their specific skill strengths and step away from daily administrative work. Peer-based masterminds sorted by revenue tier give firm leaders clear metrics for evaluating profit margins and operational expenditures. Current legal artificial intelligence software handles document summarization well, but it has not yet expanded individual paralegal case handling limits. Software adoption slows down when legal staff are required to manually log into platforms or manually click prompt buttons. Case resolution speeds improve when automated agents process medical records and deliver ready-to-review drafts directly to attorney inboxes. Developing customized internal automation tools allows plaintiff firms to analyze incident locations, social media posts, and contract releases quickly.

  7. Sep 17

    Will Hair Relaxer Settle in 2026? Daubert Showdowns in Roundup, Depo-Provera, and GLP-1 Litigation

    Key Takeaways Roundup $7.25B Approval Hearing: The final approval hearing in Missouri State Court wrapped up following objections from 150 plaintiffs regarding the $165k payout cap; a trial court ruling is expected before Thanksgiving, with new unfiled case acquisitions facing capped attorney fees of 22–25%. Depo-Provera Expert Push: While 80% of claims are settled, Pfizer is fighting remaining cases on retention dates and statute of limitations, prompting Judge Rogers to aggressively push Daubert expert hearings forward rather than pausing litigation. Weight Loss Litigation Dual Tracks: Gastroparesis claims (4,000 cases) face expert Daubert scrutiny with decisions expected by year-end, while NAION eye injury claims (200–300 cases) are mapped out for Daubert hearings in late Summer 2027. Hair Relaxer Defense Strikes: Defense counsel is attempting preemptive strikes against plaintiff epidemiologists, but Joe Fantini predicts all three cancer types (endometrial, ovarian, cervical) will clear Daubert, potentially yielding a global settlement by year-end. MTMP Preview: With Mass Torts Made Perfect at the Bellagio just a month away, a major upcoming announcement will be revealed on next week's episode.

  8. Sep 15

    The Hidden Operational Pitfalls of Law Firm Growth with Dwuan Hammond

    Key Takeaways Leverage means driving a higher output ratio relative to invested inputs rather than simply expanding firm size, which can lead to growing out of business. Law firms frequently purchase software without calculating a projected return on investment or building a strategy to reduce labor costs. Technology vendors should be held accountable through one-year contracts that mandate 90-day performance review cycles. Over 90 percent of law firms should buy existing software tools rather than attempting to build custom AI solutions in-house. Intake requires human empathy and sales capabilities, making it a career-track role that warrants top compensation rather than automation. Credit lines should be reserved for high-yield growth assets like marketing rather than funding routine operational expenses or payroll. Reinvesting a minimum of 50 percent of profits back into the firm creates long-term value and financial stability.

See All (114)

Ratings & Reviews

5
out of 5
3 Ratings

About

Legal growth insights from Jon, Marc, and the industry's top tier legal & marketing professionals. Two veteran legal marketers, Jon Robinson and Marc Rioux, dive into the business of law, mass torts, and the future of plaintiff-side firms. From marketing strategy and technology to candid conversations with top trial lawyers, marketers, and industry leaders, this podcast unpacks what’s really driving growth and change in the legal world. Honest, practical, and a little irreverent—perfect for attorneys, marketers, and anyone curious about where the business of law is headed.

Information

  • Creator
    Jon and Marc
  • Years Active
    2025 - 2026
  • Episodes
    114
  • Rating
    Explicit
  • Copyright
    © Jon and Marc
  • Show Website
    The Jon and Marc Podcast

You Might Also Like